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Analysis of Risk Factors in Hypertension Patients with Chronic Kidney
Disease Stage 5
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China
Objective: To analyse the risk factors for hypertension patients with chronic
kidney disease stage 5 (CKD5).
Methods: Collecting 390 hypertension patients with CKD5, recording the
basic information. Gender, age, primary disease, dialysis method, BMI, com-
plications (hyperlipidemia, high uric acid, cardiac insufficiency), level of ed-
ucation, PTH were first examined by using univariate analysis. Univariate
variables that showed statistical significance were then subjected to the
multivariate analysis (logistic regression) to identify the risk factors for hy-
pertension patients with CKD5; evaluating the level of DDD according to hy-
pertension segmented standard;
Results: Overall hypertension control rate is 22.8%. (1) Univariate analysis
showed the following variables had significant differences: > 40 years old,
male, diabetic nephropathy, hypertensive nephropathy, hemodialysis, hyperli-
pemia, highPTH(P<0.05). (2) Logisticmultivariateanalysis showed that diabetic
nephropathy, hyperlipidemia, high PTHwere themajor risk factors for hyperten-
sion patients with CKD5. (3) In hypertension segmented standard, the level of
DDD was no different between 0 and 1 standard (P>0.05), DDD of 2 and 3 para-
graphswere increased significantly compared with 0 and 1 paragraphs (P<0.05).
Conclusion: Overall hypertension control rate is only 22.8% in hypertension
patients with CKD 5. Diabetic nephropathy, hyperlipidemia and high PTH are
independent risk factors in hypertension patients with CKD5.http://dx.doi.org/10.1016/j.hkjn.2015.08.0690009
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Objective: Nonapnea sleep disorders (NASD) and sleep-related problems,
which are high prevalent in patients with kidney diseases, are associated
with cardiovascular disease, type 2 diabetes mellitus (DM) and chronic kidney
disease (CKD). However, whether NASD is associated with acute kidney injury
(AKI) development and prognosis have not been thoroughly investigated. The
aim of this study is to determine whether NASD is an independent risk factor of
AKI by using the database of National Health Insurance Research Database
(NHIRD), which is one of the largest medical databases of the world.
Methods: The retrospective study used an 11-year nationwide database,
which random sampled of 1,000,000 individuals covered by the National
Health Insurance in Taiwan, to analyze the incidence. The patients with1561-5413NASD were identified through diagnostic and medication codes. Kaplan-
Meier and Cox regression analyses were performed.
Results: From 2000 to 2010, 9,316 newly diagnosed NASD cases compared with
27,948 control participants without sleep disorders randomly selected, fre-
quencymatchedbyage, sex, indexyear fromthegeneralpopulation.Wedemon-
strated that the NASD cohort had an adjusted hazard ratio (HR; 95% confidence
interval [CI]Z 1.16e1.71) of subsequent AKI 1.44-fold higher than that of the
cohort without sleep disorders. Elder age, lowermonthly income, hypertension,
DM, cerebrovascular disease, CKD status, depression andhigher Charlson comor-
bidity index were significant factors associated with the increased risk of AKI
(p<0.05). Male and younger (age< 65 year-old) female increased significant
risk of AKI development with NASD (HRZ2.23; 95% CIZ 1.57e3.16, p<0.001).
Conclusion: This nationwide population-based cohort study provides evi-
dence that patients with NASD are at higher risk of developing AKI than peo-
ple without NASD.http://dx.doi.org/10.1016/j.hkjn.2015.08.0700039
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Objective: Angiotensin II (Ang II) has been recognized as a key mediator in
chronic kidney disease (CKD), particularly in hypertension-associated nephrop-
athy. Increasing evidence shows that the angiotensin-converting enzyme 2
(ACE2)/Ang1-7/Mas receptor (Mas) axis plays a protective role in CKD by
counter-regulating the pathogenic actions of the ACE/Ang II/Ang II type 1 re-
ceptor (AT1) axis. In this study, we investigated the role and underlying mech-
anisms of the ACE2/Ang 1-7/Mas axis in Ang II-mediated renal injury.
Methods: A mouse model of hypertension was induced in ACE2 knockout
(KO), Mas KO, double ACE2/Mas KO and their littermate wild-type (WT)
mice by subcutaneous infusion of Ang II (1.0 mg/kg/day) or control saline
for 28 days via osmotic mini-pumps. Blood pressure, serum creatinine (Scr)
and creatinine clearance (Ccr), renal fibrosis including a-SMA and collagen
matrix deposition, and signaling pathways related to Ang II-mediated renal
fibrosis including ERK/MAP kinase and TGF-b/Smad signaling were examined.
Results: Deletion of ACE2 or Mas developed higher levels of blood pressure
compared to WT mice, which was further increased in mice with double
ACE2/Mas deletion at day 7 after Ang II infusion. Moreover, compared to sin-
gle ACE2 or Mas KO mice, mice with double ACE2/Mas KO developed more
severe hypertensive nephropathy as demonstrated by higher levels of Scr,
a fall in Ccr, and progressive renal fibrosis with a marked accumulation of
a-SMA+ myofibroblasts and collagen I matrix. Further study revealed that
the development of more severe kidney injury in double ACE2/Mas KO
mice was associated with enhanced AT1-dependent activation of ERK/MAP
kinase-Smad3 crosstalk pathway.
